KANESA-THASAN NIRANJAN (Chief Medical Officer) sold 5.0% of their position (11.88K shares) of ICOSAVAX, INC. on the open market
Open‑market sale worth $183.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/22/2023ACC: 0001209191-23-059621
Officer· Chief Medical Officer
Since Jul 2021
-11.88K
Net shares
Net seller
$183.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.88K
Price / share
$15.46
Trade value
$183.69K
% of position
5.0%
12/20/2023
235.86K→223.98K
Total
Net shares
−11.88K
Net value
-$183.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2023 | S · Sale | −11.88K | $15.46 | $183.69K | 5.0% | 235.86K | 223.98K |
| Total | −11.88K | -$183.69K | ||||||
Derivative Transactions0
No derivative transactions reported